A novel approach for integrative studies on neurodegenerative diseases in human brains

被引:12
|
作者
Theofilas, Panos [1 ]
Polichiso, Livia [1 ,2 ]
Wang, Xuehua [1 ]
Lima, Luzia C. [2 ,3 ]
Alho, Ana T. L. [2 ,3 ]
Leite, Renata E. P. [4 ]
Suemoto, Claudia K. [5 ]
Pasqualucci, Carlos A. [4 ]
Jacob-Filho, Wilson [5 ]
Heinsen, Helmut [6 ]
Grinberg, Lea T. [1 ,2 ]
机构
[1] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA 94143 USA
[2] Univ Sao Paulo, Discipline Pathophysiol, Sch Med, BR-01246903 Sao Paulo, SP, Brazil
[3] Hosp Israelita Brasileiro Albert Einstein, Sao Paulo, SP, Brazil
[4] Univ Sao Paulo, Dept Pathol, Sch Med, LIM 22, BR-01246903 Sao Paulo, SP, Brazil
[5] Univ Sao Paulo, Div Geriatr, Sch Med, BR-01246903 Sao Paulo, SP, Brazil
[6] Univ Wurzburg, Dept Psychiat, Lab Morphol Brain Res, D-97080 Wurzburg, Germany
关键词
Brainstem; Stereology; 3D reconstruction; Neuropathology; Human; Immunohistochemistry; Brain network; Alzheimer's disease; Neurodegenerative diseases; DORSAL RAPHE NUCLEUS; ALZHEIMERS-DISEASE; 3-DIMENSIONAL RECONSTRUCTION; ENTORHINAL CORTEX; SERIAL SECTIONS; AGING BRAIN; STEREOLOGY; TISSUE; ABNORMALITIES; PATHOLOGY;
D O I
10.1016/j.jneumeth.2014.01.030
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Despite a massive research effort to elucidate Alzheimer's disease (AD) in recent decades, effective treatment remains elusive. This failure may relate to an oversimplification of the pathogenic processes underlying AD and also lack of understanding of AD progression during its long latent stages. Although evidence shows that the two specific neuropathological hallmarks in AD (neuronal loss and protein accumulation), which are opposite in nature, do not progress in parallel, the great majority of studies have focused on only one of these aspects. Furthermore, research focusing on single structures is likely to render an incomplete picture of AD pathogenesis because as AD involves complete brain networks, potential compensatory mechanisms within the network may ameliorate impairment of the system to a certain extent. Here, we describe an approach for enabling integrative analysis of the dual-nature lesions, simultaneously, in all components of one of the brain networks most vulnerable to AD. This approach is based on significant development of methods previously described mainly by our group that were optimized and complemented for this study. It combines unbiased stereology with immunohistochemistry and immunofluorescence, making use of advanced graphics computing for three-dimensional (3D) volume reconstructions. Although this study was performed in human brainstem and focused in AD, it may be applied to the study of any neurological disease characterized by dual-nature lesions, in humans and animal models. This approach does not require a high level of investment in new equipment and a significant number of specimens can be processed and analyzed within a funding cycle. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:171 / 183
页数:13
相关论文
共 50 条
  • [41] A neuroprotectant, PAN-811, representing a novel neuroprotective approach to treat neurodegenerative diseases
    Jiang, ZG
    Almassian, B
    Nelson, V
    Ghanbari, HA
    NEUROBIOLOGY OF AGING, 2004, 25 : S202 - S202
  • [42] "Endothelial Antibody Factory" at the Blood Brain Barrier: Novel Approach to Therapy of Neurodegenerative Diseases
    Thinard, Reynald
    Farkas, Attila E.
    Halasa, Marta
    Chevalier, Melanie
    Brodaczewska, Klaudia
    Majewska, Aleksandra
    Zdanowski, Robert
    Paprocka, Maria
    Rossowska, Joanna
    Duc, Lam Tri
    Greferath, Ruth
    Krizbai, Istvan
    Van Leuven, Fred
    Kieda, Claudine
    Nicolau, Claude
    PHARMACEUTICS, 2022, 14 (07)
  • [43] Network approaches for omics studies of neurodegenerative diseases
    Zhao, Na
    Quicksall, Zachary
    Asmann, Yan W. W.
    Ren, Yingxue
    FRONTIERS IN GENETICS, 2022, 13
  • [44] Novel neurotrophic factors for the treatment of neurodegenerative diseases
    Saarma, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S128 - S129
  • [45] Proteomics Approach to Identify Biomarkers in Neurodegenerative Diseases
    Nayak, Annapurna
    Salt, Gregory
    Verma, Sunil K.
    Kishore, Uday
    OMIC STUDIES OF NEURODEGENERATIVE DISEASE, PT A, 2015, 121 : 59 - 86
  • [46] Oxidative Stress and Neurodegenerative Diseases: A Neurotrophic Approach
    Espinet, Carme
    Gonzalo, Hugo
    Fleitas, Catherine
    Menal, Maria Jose
    Egea, Joaquim
    CURRENT DRUG TARGETS, 2015, 16 (01) : 20 - 30
  • [47] Medicinal Chemistry Studies Against Neurodegenerative Diseases
    Scotti, Luciana
    Scotti, Marcus T.
    CURRENT NEUROPHARMACOLOGY, 2022, 20 (05) : 822 - 823
  • [48] PERK: a novel therapeutic target for neurodegenerative diseases?
    Ma, Tao
    Klann, Eric
    ALZHEIMERS RESEARCH & THERAPY, 2014, 6 (03):
  • [49] PERK: a novel therapeutic target for neurodegenerative diseases?
    Tao Ma
    Eric Klann
    Alzheimer's Research & Therapy, 6
  • [50] Resveratrol: A Therapeutic Approach to Neurodegenerative Diseases and Aging
    Pallas, M.
    Canudas, A. M.
    Junyent, F.
    Jimenez, A.
    Verdaguer, E.
    Camins, A.
    MINI-REVIEWS IN ORGANIC CHEMISTRY, 2010, 7 (04) : 267 - 271